Chantal Rothschild

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

Journal: Haematologica

Published: February 02, 2019

Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal.

Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: July 22, 2017

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.

Journal: Haematologica

Published: June 16, 2017

Molecular diagnosis of haemophilia A in patients from Senegal.

Molecular diagnosis of haemophilia A in patients from Senegal.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 24, 2017

Long-term results of ankle arthrodesis in children and adolescents with haemophilia.

Long-term results of ankle arthrodesis in children and adolescents with haemophilia.

Journal: International orthopaedics

Published: January 05, 2017

LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.

LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.

Journal: JCI insight

Published: October 14, 2016

A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfa.

A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfa.

Journal: Transfusion

Published: June 20, 2016

Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.

Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.

Journal: Vox sanguinis

Published: December 30, 2015

Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.

Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.

Journal: PloS one

Published: September 02, 2015

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.

Journal: Blood

Published: June 13, 2015

Open synovectomy of the ankle joint in young haemophiliacs: mid-term to long- term results of a single-centre series of 32 procedures.

Open synovectomy of the ankle joint in young haemophiliacs: mid-term to long- term results of a single-centre series of 32 procedures.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 31, 2015

Long-term follow-up of children with haemophilia - low incidence of infections with central venous access devices.

Long-term follow-up of children with haemophilia - low incidence of infections with central venous access devices.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 04, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026